Evidence suggests that hyperinsulinemia may play a key role directly or by enhancing the bioavailability of insulin-like growth factor-1 (IGF-1), a stimulant for tumor growth and development (6,9–11). The gene discussed is IGF1; the disease is hyperinsulinism.